<p>There is provided polymorphic forms of Rifaximin; namely substantially pure APO-I and APO-II. Also provided are processes for preparing substantially pure APO-I and APO-II.</p>
申请公布号
WO2011156897(A2)
申请公布日期
2011.12.22
申请号
WO2011CA00690
申请日期
2011.06.16
申请人
APOTEX PHARMACHEM INC.;KOTHAKONDA, KIRAN KUMAR;REY, ALLAN W.
